4.6 Article

The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study

Daryl Ramai et al.

Summary: Fibrolamellar hepatocellular carcinoma (FLC) accounts for 1-2% of all cases of hepatocellular carcinoma in the USA. The study found a bimodal distribution of FLC, with the highest incidences in the age groups 15-19 years and 70-74 years. Surgical intervention is superior to chemotherapy and radiation, and FLC has a higher recurrence rate but better survival outcome compared to HCC.

DIGESTIVE DISEASES AND SCIENCES (2021)

Editorial Material Cell Biology

The 2019 WHO classification of tumours of the digestive system

Iris D. Nagtegaal et al.

HISTOPATHOLOGY (2020)

Article Gastroenterology & Hepatology

The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis

Christoph Jakob Ackermann et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)

Article Gastroenterology & Hepatology

Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers

Min-Hoe Chew et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)

Article Gastroenterology & Hepatology

Significance of signet-ring cells in patients with colorectal cancer

Rashmi Pande et al.

DISEASES OF THE COLON & RECTUM (2008)

Article Surgery

Treatment outcomes in patients with signet ring cell carcinoma of the colorectum

Won-Suk Lee et al.

AMERICAN JOURNAL OF SURGERY (2007)

Article Gastroenterology & Hepatology

A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum

HJ Kang et al.

DISEASES OF THE COLON & RECTUM (2005)

Article Gastroenterology & Hepatology

Clinical significance of signet ring cell rectal carcinoma

JS Chen et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2004)

Article Medicine, General & Internal

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer

T Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Surgery

Primary signet-ring cell carcinoma of the colorectum

B Bittorf et al.

LANGENBECKS ARCHIVES OF SURGERY (2004)